170 related articles for article (PubMed ID: 37920834)
1. Factors affecting progression of non-Alzheimer dementia: a retrospective analysis with long-term follow-up.
Ghouri R; Öksüz N; Taşdelen B; Özge A
Front Neurol; 2023; 14():1240093. PubMed ID: 37920834
[TBL] [Abstract][Full Text] [Related]
2. Mild Cognitive Impairment Progression and Alzheimer's Disease Risk: A Comprehensive Analysis of 3553 Cases over 203 Months.
Öksüz N; Ghouri R; Taşdelen B; Uludüz D; Özge A
J Clin Med; 2024 Jan; 13(2):. PubMed ID: 38256652
[TBL] [Abstract][Full Text] [Related]
3. Predictive factors for Alzheimer's disease progression: a comprehensive retrospective analysis of 3,553 cases with 211 months follow-up.
Özge A; Ghouri R; Öksüz N; Taşdelen B
Front Neurol; 2023; 14():1239995. PubMed ID: 37693748
[TBL] [Abstract][Full Text] [Related]
4. White matter hyperintensities on MRI in dementia with Lewy bodies, Parkinson's disease with dementia, and Alzheimer's disease.
Joki H; Higashiyama Y; Nakae Y; Kugimoto C; Doi H; Kimura K; Kishida H; Ueda N; Nakano T; Takahashi T; Koyano S; Takeuchi H; Tanaka F
J Neurol Sci; 2018 Feb; 385():99-104. PubMed ID: 29406924
[TBL] [Abstract][Full Text] [Related]
5. Predictors of Mortality in Individuals with Dementia in the National Alzheimer's Coordinating Center.
Armstrong MJ; Song S; Kurasz AM; Li Z
J Alzheimers Dis; 2022; 86(4):1935-1946. PubMed ID: 35253760
[TBL] [Abstract][Full Text] [Related]
6. Use of Cholinesterase Inhibitors in Non-Alzheimer's Dementias.
Noufi P; Khoury R; Jeyakumar S; Grossberg GT
Drugs Aging; 2019 Aug; 36(8):719-731. PubMed ID: 31201687
[TBL] [Abstract][Full Text] [Related]
7. The ABC of Alzheimer's disease: cognitive changes and their management in Alzheimer's disease and related dementias.
Corey-Bloom J
Int Psychogeriatr; 2002; 14 Suppl 1():51-75. PubMed ID: 12636180
[TBL] [Abstract][Full Text] [Related]
8. Hippocampal atrophy on MRI in frontotemporal lobar degeneration and Alzheimer's disease.
van de Pol LA; Hensel A; van der Flier WM; Visser PJ; Pijnenburg YA; Barkhof F; Gertz HJ; Scheltens P
J Neurol Neurosurg Psychiatry; 2006 Apr; 77(4):439-42. PubMed ID: 16306153
[TBL] [Abstract][Full Text] [Related]
9. Inflammatory panel cytokines are elevated in the neocortex of late-stage Alzheimer's disease but not Lewy body dementias.
Chai YL; Lee JH; Chong JR; Ballard C; Francis PT; Kennedy BK; Arumugam TV; Chen CP; Aarsland D; Lai MKP
J Neuroinflammation; 2023 May; 20(1):111. PubMed ID: 37158957
[TBL] [Abstract][Full Text] [Related]
10. Can clock drawing differentiate Alzheimer's disease from other dementias?
Tan LP; Herrmann N; Mainland BJ; Shulman K
Int Psychogeriatr; 2015 Oct; 27(10):1649-60. PubMed ID: 26138809
[TBL] [Abstract][Full Text] [Related]
11. MRI confirms mild cognitive impairments prodromal for Alzheimer's, vascular and Parkinson-Lewy body dementias.
Meyer JS; Huang J; Chowdhury MH
J Neurol Sci; 2007 Jun; 257(1-2):97-104. PubMed ID: 17316690
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic patterns of regional atrophy on MRI and regional cerebral blood flow change on SPECT in young onset patients with Alzheimer's disease, frontotemporal dementia and vascular dementia.
Varma AR; Adams W; Lloyd JJ; Carson KJ; Snowden JS; Testa HJ; Jackson A; Neary D
Acta Neurol Scand; 2002 Apr; 105(4):261-9. PubMed ID: 11939938
[TBL] [Abstract][Full Text] [Related]
13. Accurate prediction of histologically confirmed Alzheimer's disease and the differential diagnosis of dementia: the use of NINCDS-ADRDA and DSM-III-R criteria, SPECT, X-ray CT, and APO E4 medial temporal lobe dementias. The Oxford Project to Investigate Memory and Aging.
Jobst KA; Barnetson LP; Shepstone BJ
Int Psychogeriatr; 1997; 9 Suppl 1():191-222; discussion 247-52. PubMed ID: 9447442
[TBL] [Abstract][Full Text] [Related]
14. Caregiver burden, sleep quality, depression, and anxiety in dementia caregivers: a comparison of frontotemporal lobar degeneration, dementia with Lewy bodies, and Alzheimer's disease.
Liu S; Liu J; Wang XD; Shi Z; Zhou Y; Li J; Yu T; Ji Y
Int Psychogeriatr; 2018 Aug; 30(8):1131-1138. PubMed ID: 29223171
[TBL] [Abstract][Full Text] [Related]
15. Serum Homocysteine, Vitamin B12, Folate, and Their Association with Mild Cognitive Impairment and Subtypes of Dementia.
Song Y; Quan M; Li T; Jia J
J Alzheimers Dis; 2022; 90(2):681-691. PubMed ID: 36155508
[TBL] [Abstract][Full Text] [Related]
16. Mini-Mental State Examination (MMSE) for the detection of Alzheimer's disease and other dementias in people with mild cognitive impairment (MCI).
Arevalo-Rodriguez I; Smailagic N; Roqué I Figuls M; Ciapponi A; Sanchez-Perez E; Giannakou A; Pedraza OL; Bonfill Cosp X; Cullum S
Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD010783. PubMed ID: 25740785
[TBL] [Abstract][Full Text] [Related]
17. Neuropsychiatric symptoms and α-Synuclein profile of patients with Parkinson's disease dementia, dementia with Lewy bodies and Alzheimer's disease.
Bougea A; Stefanis L; Paraskevas GP; Emmanouilidou E; Efthymiopoulou E; Vekrelis K; Kapaki E
J Neurol; 2018 Oct; 265(10):2295-2301. PubMed ID: 30083953
[TBL] [Abstract][Full Text] [Related]
18. Significance of cerebral amyloid angiopathy and other co-morbidities in Lewy body diseases.
Jellinger KA
J Neural Transm (Vienna); 2021 May; 128(5):687-699. PubMed ID: 33928445
[TBL] [Abstract][Full Text] [Related]
19. Comparisons of clinical symptoms in biomarker-confirmed Alzheimer's disease, dementia with Lewy bodies, and frontotemporal dementia patients in a local memory clinic.
Shea YF; Ha J; Chu LW
Psychogeriatrics; 2015 Dec; 15(4):235-41. PubMed ID: 25533477
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
